Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Sees Large Decline in Short Interest
Intellipharmaceutics International Inc. (OTCMKTS:IPCIF) Sees Large Decline in Short Interest
Receive News & Ratings for Intellipharmaceutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellipharmaceutics International and related companies with MarketBeat.com's FREE daily email newsletter.Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Rating) (TSE:I) was the recipient of a significant drop in short interest in December. As of December 30th, there was short interest totalling 500 shares, a drop of 96.2% from the December 15th total of 13,200 shares. Based on an average daily volume of 30,800 shares, the days-to-cover ratio is currently 0.0 days.
國際智能藥品有限公司 (OTCMKTS: IPCIF — 獲得評級) (TSE: I) 是在十二月份短期利益顯著下降的收件人.截至 12 月 30 日，總共有 500 股短期利息，較十二月十五日總額 13,200 股股份下降了 96.2%。根據每日平均成交量為 30,800 股，日數佔覆蓋率目前為 0.0 天。
Intellipharmaceutics International Stock Performance
國際智能製藥股表現
Shares of OTCMKTS IPCIF remained flat at $0.08 during midday trading on Thursday. The firm has a market capitalization of $2.54 million, a P/E ratio of -0.32 and a beta of 1.51. Intellipharmaceutics International has a one year low of $0.06 and a one year high of $0.16. The company's 50-day moving average is $0.08 and its 200-day moving average is $0.09.
週四午間交易期間，OTCMKTS IPCIF 的股份保持平穩於 0.08 美元。該公司的市值為 2.54 萬美元，市盈率為 -0.32，貝塔值為 1.51。國際智能製藥有一年的低點 0.06 美元和一年的新高 0.16 美元。該公司的 50 天移動平均線為 0.08 美元，其 200 天移動平均線為 0.09 美元。
About Intellipharmaceutics International
關於國際智能製藥
(Get Rating)
(取得評分)
Featured Articles
特色文章
- Get a free copy of the StockNews.com research report on Intellipharmaceutics International (IPCIF)
- Mid-Stream Operator Kinder Morgan: A High-Yield Value For 2023
- Why is T-mobile Down Despite Strong Preliminary Q4 Results?
- Procter & Gamble Earnings: A Gamble Worth Taking
- Stocks Slide, Economic Report Paints Gloomy Picture For Economy
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- 獲取有關國際智能藥學研究報告的免費副本
- 中流運營商金德摩根：2023 年的高收益值
- 儘管初步 Q4 結果強勁，但為什麼 T-移動仍然下降？
- 寶潔公司的收益：值得參加的賭博
- 股票幻燈片，經濟報告描繪經濟陰沉的圖片
- NU 控股股票與沃倫·巴菲特有什麼關係？
Receive News & Ratings for Intellipharmaceutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellipharmaceutics International and related companies with MarketBeat.com's FREE daily email newsletter.
接收國際智能製藥日報的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件時事通訊接收有關國際智能藥學和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。
